Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Did you (or injured party) experience any of the following while taking Ketek?

   * Please describe your case:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Replidyne halts faropenem test using Ketek

Jan 1, 2006

U.S. firm Replidyne said Tuesday it has temporarily halted its study comparing faropenem to Ketek, due to the latter drug's safety issue.

The company said it has been conducting a phase 3 clinical trial comparing faropenem medoxomil to placebo and to the antibiotic Ketek in patients being treated for acute exacerbation of chronic bronchitis (AECB).

Replidyne said it has put that study on hold while it considers whether to exclude from the trial the Ketek treatment arm, in light of recent data linking the antibiotic to liver damage.

The company said it made the decision based on the recommendations of an FDA advisory panel issued in mid-December that the risks of Ketek outweigh the benefits of using the drug for the treatment of patients with AECB.

"We believe that stopping enrollment in this trial to consider the inclusion of Ketek in the study is the appropriate and responsible action at this time to consider the new scientific evidence presented at the recent FDA Advisory Committee meeting," said Kenneth Collins, president and CEO of Replidyne.

Collins noted that, while the temporary suspension of the trial would cause some delay, he added, "we do not expect that it will impact the total time to complete the clinical program."

Collins also said the decision would not impact the company's development of its pediatric clinical program for faropenem.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo